Your browser doesn't support javascript.
loading
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial.
Diaz, Rafael; Li, Qian H; Bhatt, Deepak L; Bittner, Vera A; Baccara-Dinet, Marie T; Goodman, Shaun G; Jukema, J Wouter; Kimura, Takeshi; Parkhomenko, Alexander; Pordy, Robert; Reiner, Zeljko; Roe, Matthew T; Szarek, Michael; Tse, Hung-Fat; White, Harvey D; Zahger, Doron; Zeiher, Andreas M; Schwartz, Gregory G; Steg, Ph Gabriel.
Afiliação
  • Diaz R; Estudios Clínicos Latino América, Instituto Cardiovascular de Rosario, Argentina.
  • Li QH; Regeneron Pharmaceuticals Inc., Tarrytown, USA.
  • Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, USA.
  • Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, USA.
  • Baccara-Dinet MT; Sanofi R&D, Montpellier, France.
  • Goodman SG; Canadian VIGOUR Centre, University of Alberta, Canada.
  • Jukema JW; St Michael's Hospital, University of Toronto, Canada.
  • Kimura T; Department of Cardiology, Leiden University Medical Center, The Netherlands.
  • Parkhomenko A; Kyoto University, Graduate School of Medicine, Japan.
  • Pordy R; MD Strazhesko Institute of Cardiology, AMS of Ukraine, Ukraine.
  • Reiner Z; Regeneron Pharmaceuticals Inc., Tarrytown, USA.
  • Roe MT; University Hospital Center Zagreb, University of Zagreb, Croatia.
  • Szarek M; Duke Clinical Research Institute, Duke University Medical Center, USA.
  • Tse HF; State University of New York, Downstate School of Public Health, USA.
  • White HD; Queen Mary Hospital, Hong Kong, Special Administrative Region of the People's Republic of China.
  • Zahger D; Green Lane Cardiovascular Services, Auckland City Hospital, New Zealand.
  • Zeiher AM; Soroka University Medical Center, Ben Gurion University of the Negev, Israel.
  • Schwartz GG; Department of Medicine III, Goethe University, Germany.
  • Steg PG; Division of Cardiology, University of Colorado School of Medicine, USA.
Eur J Prev Cardiol ; 28(1): 33-43, 2021 03 23.
Article em En | MEDLINE | ID: mdl-33755145
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Inibidores de Hidroximetilglutaril-CoA Redutases / Acidente Vascular Cerebral / Síndrome Coronariana Aguda / Anticolesterolemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Argentina
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Inibidores de Hidroximetilglutaril-CoA Redutases / Acidente Vascular Cerebral / Síndrome Coronariana Aguda / Anticolesterolemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Argentina